
PG
Procter & Gamble Co
- Overview
- Forecast
- Valuation
- Earnings

Line
|

Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
155.565
Open
153.780
VWAP
154.89
Vol
7.34M
Mkt Cap
363.64B
Low
153.630
Amount
1.14B
EV/EBITDA(TTM)
16.78
Total Shares
2.36B
EV
389.72B
EV/OCF(TTM)
20.97
P/S(TTM)
4.55
The Procter & Gamble Company is focused on providing branded consumer packaged goods to consumers across the world. The Company’s segments include Beauty, Grooming, Health Care, Fabric & Home Care and Baby, Feminine & Family Care. The Company’s products are sold in approximately 180 countries and territories primarily through mass merchandisers, e-commerce, including social commerce channels, grocery stores, membership club stores, drug stores, department stores, distributors, wholesalers, specialty beauty stores, including airport duty-free stores), high-frequency stores, pharmacies, electronics stores and professional channels. It also sells direct to individual consumers. It has operations in approximately 70 countries. It offers products under brands, such as Head & Shoulders, Herbal Essences, Pantene, Rejoice, Olay, Old Spice, Safeguard, Secret, SK-II, Braun, Gillette, Venus, Crest, Oral-B, Ariel, Downy, Gain, Tide, Always, Always Discreet, Tampax, Bounty and others.
Show More
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q4
FY2026Q1
FY2026Q2
20.84B
+1.49%
1.420
+1.43%
22.22B
+2.21%
1.955
+1.28%
22.48B
+2.73%
1.965
+4.5%
Estimates Revision
The market is revising Downward the revenue expectations for The Procter & Gamble Company (PG) for FY2025, with the revenue forecasts being adjusted by -0.91% over the past three months. During the same period, the stock price has changed by -6.43%.
Revenue Estimates for FY2025
Revise Downward

-0.91%
In Past 3 Month
EPS Estimates for FY2025
Revise Downward

-1.33%
In Past 3 Month
Stock Price
Go Down

-6.43%
In Past 3 Month
20 Analyst Rating

10.79% Upside
Wall Street analysts forecast PG stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for PG is 171.83 USD with a low forecast of 152.00 USD and a high forecast of 190.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
11 Buy
9 Hold
0 Sell
Moderate Buy

10.79% Upside
Current: 155.100

Low
152.00
Averages
171.83
High
190.00

10.79% Upside
Current: 155.100

Low
152.00
Averages
171.83
High
190.00
UBS
Peter Grom
Buy
maintain
$186 -> $180
2025-07-17
New
Reason
UBS
Peter Grom
Price Target
$186 -> $180
2025-07-17
New
maintain
Buy
Reason
UBS analyst Peter Grom lowered the firm's price target on Procter & Gamble to $180 from $186 and keeps a Buy rating on the shares.
Barclays
Lauren Lieberman
Equal Weight
maintain
$160 -> $161
2025-07-15
New
Reason
Barclays
Lauren Lieberman
Price Target
$160 -> $161
2025-07-15
New
maintain
Equal Weight
Reason
Barclays analyst Lauren Lieberman raised the firm's price target on Procter & Gamble to $161 from $160 and keeps an Equal Weight rating on the shares. The firm adjusted price targets in the staples group as a part of a Q2 preview. Investor expectations "feel subdued" into earnings season, the analyst tells investors in a research note.
Evercore ISI
Outperform -> In Line
downgrade
$190 -> $170
2025-07-14
Reason
Evercore ISI
Price Target
$190 -> $170
2025-07-14
downgrade
Outperform -> In Line
Reason
Evercore ISI downgraded Procter & Gamble to In Line from Outperform with a price target of $170, down from $190. Evercore expects a fiscal 2026 outlook with a "low but broad range" of scenarios to be issued on July 29 when Procter & Gamble reports Q4 results, the analyst tells investors in a research note. Macro pressures are transient, but the firm's concern lies in adverse shifts in retail channels that challenge Procter's growth potential, and could cap Procter's sales growth below the 4% needed to drive operating leverage, the firm says.
RBC Capital
Nik Modi
Sector Perform
to
Outperform
upgrade
$164 -> $177
2025-04-25
Reason
RBC Capital
Nik Modi
Price Target
$164 -> $177
2025-04-25
upgrade
Sector Perform
to
Outperform
Reason
RBC Capital analyst Nik Modi upgraded Procter & Gamble to Outperform from Sector Perform with a price target of $177, up from $164. While the company's quarter had its challenges, "this was a clearing event," materially cutting numbers while protecting investments needed for sustainable long term growth, the analyst tells investors in a research note. The firm thinks investors should take advantage of Procter's share pullback, "especially in this market." RBC believe s the company's revised guidance embeds assumptions that are realistic and achievable.
BofA
Bryan Spillane
Buy
downgrade
$190 -> $180
2025-04-25
Reason
BofA
Bryan Spillane
Price Target
$190 -> $180
2025-04-25
downgrade
Buy
Reason
BofA analyst Bryan Spillane lowered the firm's price target on Procter & Gamble to $180 from $190 and keeps a Buy rating on the shares. The firm's key takeaway from P&G's Q3 results is that the underlying business continues to perform well despite tariff impacts, the analyst tells investors. Given the stock's reaction on April 24, the firm believes the market is pricing in "a worst-case scenario on tariffs," though P&G anticipates these are possible to mitigate through favorable foreign exchange, declining commodity costs, and pricing/innovation, the analyst added.
Citi
Buy
maintain
$200 -> $181
2025-04-25
Reason
Citi
Price Target
$200 -> $181
2025-04-25
maintain
Buy
Reason
Citi lowered the firm's price target on Procter & Gamble to $181 from $200 and keeps a Buy rating on the shares. Despite "well-telegraphed headwinds," Procter & Gamble delivered a fiscal Q3 miss net of a small earnings beat and lowered fiscal 2025 guidance, the analyst tells investors in a research note. The firm suspects the company is now past retail destocking headwinds in the U.S. and continues to make sequential progress on China. It lowered estimates but continues to view Procter & Gamble's execution as solid. Citi closed its negative short-term view on the shares.
See All Ratings
Valuation Metrics
The current forward P/E ratio for Procter & Gamble Co (PG.N) is 22.38, compared to its 5-year average forward P/E of 24.00. For a more detailed relative valuation and DCF analysis to assess Procter & Gamble Co 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

Undervalued
5Y Average PE
24.00
Current PE
22.38
Overvalued PE
25.16
Undervalued PE
22.84
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

Undervalued
5Y Average EV/EBITDA
17.15
Current EV/EBITDA
16.21
Overvalued EV/EBITDA
17.98
Undervalued EV/EBITDA
16.32
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

Fair
5Y Average PS
4.37
Current PS
4.23
Overvalued PS
4.61
Undervalued PS
4.14
Financials
Annual
Quarterly
FY2025Q3
YoY :
-2.07%
19.78B
Total Revenue
FY2025Q3
YoY :
+1.72%
4.61B
Operating Profit
FY2025Q3
YoY :
+0.34%
3.79B
Net Income after Tax
FY2025Q3
YoY :
+1.32%
1.54
EPS - Diluted
FY2025Q3
YoY :
-13.49%
2.85B
Free Cash Flow
FY2025Q3
YoY :
-0.62%
51.10
Gross Profit Margin - %
FY2025Q3
YoY :
-6.87%
17.90
FCF Margin - %
FY2025Q3
YoY :
+2.40%
19.17
Net Margin - %
FY2025Q3
YoY :
-0.67%
19.20
ROIC
Trading Trends
Insider
Insiders areSelling! The selling amount has increased 934.3% over the last month.
Sold
0-3
Months
1.7M
USD
1
3-6
Months
9.3M
USD
3
6-9
Months
25.6M
USD
3
0-12
Months
71.6M
USD
31
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
505.9K
Volume
22
6-9
Months
524.1K
Volume
32
0-12
Months
2.0K
Volume
1
Bought
0-3
0
0.0
Volume
Months
3-6
12
406.3K
Volume
Months
6-9
25
767.8K
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
32.5K
USD
1
3-6
Months
438.0K
USD
11
6-9
Months
24.0K
USD
3
0-12
Months
8.0K
USD
1
Bought
0-3
4
32.0K
USD
Months
3-6
6
48.0K
USD
Months
6-9
1
8.0K
USD
Months
0-12
4
32.0K
USD
Months
Insider
Insiders areSelling! The selling amount has increased 934.3% over the last month.
Sold
0-3
Months
1.7M
USD
1
3-6
Months
9.3M
USD
3
6-9
Months
25.6M
USD
3
0-12
Months
71.6M
USD
31
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
PG News & Events
Events Timeline
2025-06-05 (ET)
2025-06-05
05:40:20
Procter & Gamble to cut 7,000 jobs in next 2 years, WSJ reports


2025-04-24 (ET)
2025-04-24
09:31:58
Procter & Gamble says planning for a 'wide outcome' in Q4

2025-04-24
09:12:32
Procter & Gamble says consumers' logical response to tariffs is to 'pause'

Sign Up For More Events
Sign Up For More Events
News
8.0
07-19NASDAQ.COMNotable Friday Option Activity: PG, WDAY, WYNN
4.0
07-19SeekingAlphaNotable analyst calls this week: Procter & Gamble, Palantir and Shopify among top picks
1.0
07-18WSJThe 60-Year-Old Beauty Exec Who’s Cracking the Code on Gen Z
Sign Up For More News
People Also Watch

ABBV
AbbVie Inc
189.260
USD
-1.12%

PEP
PepsiCo Inc
143.240
USD
-1.51%

MCD
McDonald's Corp
297.070
USD
-1.10%

CRM
Salesforce Inc
262.380
USD
+0.96%

TMO
Thermo Fisher Scientific Inc
414.750
USD
-2.41%

PFE
Pfizer Inc
24.470
USD
-0.45%

ADBE
Adobe Inc
365.790
USD
-0.18%

COST
Costco Wholesale Corp
950.950
USD
-0.31%

KO
Coca-Cola Co
69.850
USD
-1.05%

UNH
UnitedHealth Group Inc
282.650
USD
-1.88%
FAQ

What is Procter & Gamble Co (PG) stock price today?
The current price of PG is 155.1 USD — it has decreased -0.33 % in the last trading day.

What is Procter & Gamble Co (PG)'s business?

What is the price predicton of PG Stock?

What is Procter & Gamble Co (PG)'s revenue for the last quarter?

What is Procter & Gamble Co (PG)'s earnings per share (EPS) for the last quarter?

What changes have occurred in the market's expectations for Procter & Gamble Co (PG)'s fundamentals?

How many employees does Procter & Gamble Co (PG). have?
